The shareholders in Promore Pharma AB (publ), reg. no. 556639-6809, are hereby invited to attend the extraordinary shareholders’ meeting to be held on Tuesday 22 October 2019 at 2. pm. at ABG’s premises at Regeringsgatan 65 in Stockholm.
Shareholders who wish to participate in the meeting must be entered as a shareholder in the share register kept by Euroclear Sweden AB as of Wednesday 16 October 2019, give notice to the company of its intention to attend no later than Wednesday 16 October. Notification of attendance may be given in writing to the company by e-mail to email@example.com or by mail to Promore Pharma AB, Fogdevreten 2, SE-171 65 Solna, Sweden or by telephone on +46-(0)8-124 548 59.